4th TGF-B Targeted Drug Development Summit
Evvnt Promotion / evvnt
Archiv
15.10.2024 - 17.10.2024 The Clift Royal Sonesta San Francisco, 495 Geary Street, 94102 San Francisco, California, USA
Time: 9:00 AM - 5:00 PM
Kongressthemen
With 128 TGF-B targeted therapies in the clinic and 68 in the preclinical stage, the TGF-B field is currently being rejuvenated by novel approaches in immuno-oncology, and cutting edge research in fibrosis, autoimmune diseases, and beyond.
With 128 TGF-B targeted therapies in the clinic and 68 in the preclinical stage, the TGF-B field is currently being rejuvenated by novel approaches in immuno-oncology, and cutting edge research in fibrosis, autoimmune diseases, and beyond.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2479168-3?pid=4832
Speakers: Alessandra Castiglioni, Senior Scientific Manager, Genentech, Anthony Conley, Associate Professor, MD Anderson Cancer Center, and more
URL:
Brochure: https://go.evvnt.com/2479168-3?pid=4832
Speakers: Alessandra Castiglioni, Senior Scientific Manager, Genentech, Anthony Conley, Associate Professor, MD Anderson Cancer Center, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2479168-2?pid=4832
Frau Isabel Weir
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
USD 2199.00 - USD 4397.00
USD 2199.00 - USD 4397.00
Teilnehmer erwartet
1000 - 1000
1000 - 1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
